Cope AP - Search Results

1

A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritis.

Bechman K, Dalrymple A, Southey-Bassols C, Cope AP, Galloway JB. Bechman K, et al. Among authors: cope ap. BMC Rheumatol. 2020 Nov 2;4(1):70. doi: 10.1186/s41927-020-00154-3. BMC Rheumatol. 2020. PMID: 33292827 Free PMC article.

2

Clinical and serological predictors of remission in rheumatoid arthritis are dependent on treatment regimen.

Ma MH, Scott IC, Dahanayake C, Cope AP, Scott DL. Ma MH, et al. Among authors: cope ap. J Rheumatol. 2014 Jul;41(7):1298-303. doi: 10.3899/jrheum.131401. J Rheumatol. 2014. PMID: 24931951

3

Do Genetic Susceptibility Variants Associate with Disease Severity in Early Active Rheumatoid Arthritis?

Scott IC, Rijsdijk F, Walker J, Quist J, Spain SL, Tan R, Steer S, Okada Y, Raychaudhuri S, Cope AP, Lewis CM. Scott IC, et al. Among authors: cope ap. J Rheumatol. 2015 Jul;42(7):1131-40. doi: 10.3899/jrheum.141211. Epub 2015 May 15. J Rheumatol. 2015. PMID: 25979711 Free PMC article. Clinical Trial.

4

Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis-a proof of principle and exploratory trial: is dose tapering practical in good responders?

Ibrahim F, Lorente-Cánovas B, Doré CJ, Bosworth A, Ma MH, Galloway JB, Cope AP, Pande I, Walker D, Scott DL. Ibrahim F, et al. Among authors: cope ap. Rheumatology (Oxford). 2017 Nov 1;56(11):2004-2014. doi: 10.1093/rheumatology/kex315. Rheumatology (Oxford). 2017. PMID: 28968858 Free PMC article. Clinical Trial.

5

The RA-MAP Consortium: a working model for academia-industry collaboration.

Cope AP, Barnes MR, Belson A, Binks M, Brockbank S, Bonachela-Capdevila F, Carini C, Fisher BA, Goodyear CS, Emery P, Ehrenstein MR, Gozzard N, Harris R, Hollis S, Keidel S, Levesque M, Lindholm C, McDermott MF, McInnes IB, Mela CM, Parker G, Read S, Pedersen AW, Ponchel F, Porter D, Rao R, Rowe A, Schulz-Knappe P, Sleeman MA, Symmons D, Taylor PC, Tom B, Tsuji W, Verbeeck D, Isaacs JD; RA-MAP Consortium. Cope AP, et al. Nat Rev Rheumatol. 2018 Jan;14(1):53-60. doi: 10.1038/nrrheum.2017.200. Epub 2017 Dec 7. Nat Rev Rheumatol. 2018. PMID: 29213124 Free PMC article. Review.

6

Flares in Rheumatoid Arthritis Patients with Low Disease Activity: Predictability and Association with Worse Clinical Outcomes.

Bechman K, Tweehuysen L, Garrood T, Scott DL, Cope AP, Galloway JB, Ma MHY. Bechman K, et al. Among authors: cope ap. J Rheumatol. 2018 Nov;45(11):1515-1521. doi: 10.3899/jrheum.171375. Epub 2018 Sep 1. J Rheumatol. 2018. PMID: 30173149 Free PMC article.

7

Novel methodology to discern predictors of remission and patterns of disease activity over time using rheumatoid arthritis clinical trials data.

RA-MAP Consortium. RA-MAP Consortium. RMD Open. 2018 Oct 25;4(2):e000721. doi: 10.1136/rmdopen-2018-000721. eCollection 2018. RMD Open. 2018. PMID: 30487994 Free PMC article.

8

Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis.

Gullick NJ, Ibrahim F, Scott IC, Vincent A, Cope AP, Garrood T, Panayi GS, Scott DL, Kirkham BW; TITRATE Programme Investigators. Gullick NJ, et al. Among authors: cope ap. BMC Rheumatol. 2019 Feb 25;3:6. doi: 10.1186/s41927-019-0054-y. eCollection 2019. BMC Rheumatol. 2019. PMID: 30886994 Free PMC article.

9

A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis.

Bechman K, Subesinghe S, Norton S, Atzeni F, Galli M, Cope AP, Winthrop KL, Galloway JB. Bechman K, et al. Among authors: cope ap. Rheumatology (Oxford). 2019 Oct 1;58(10):1755-1766. doi: 10.1093/rheumatology/kez087. Rheumatology (Oxford). 2019. PMID: 30982883

10

Polypharmacy is associated with treatment response and serious adverse events: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.

Bechman K, Clarke BD, Rutherford AI, Yates M, Nikiphorou E, Molokhia M, Norton S, Cope AP, Hyrich KL, Galloway JB. Bechman K, et al. Among authors: cope ap. Rheumatology (Oxford). 2019 Oct 1;58(10):1767-1776. doi: 10.1093/rheumatology/kez037. Rheumatology (Oxford). 2019. PMID: 30982886

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

172 results

Search Page